Seroprevalence of HBsAg and anti-HCV for patients who admitted to third step hospital: Six-year retrospective data


TURAN D. B., KURUOĞLU T., GÜMÜŞ D., KALAYCI F., ŞEREFHANOĞLU K.

Ege Tıp Dergisi, cilt.58, sa.2, ss.149-153, 2019 (Hakemli Dergi) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58 Sayı: 2
  • Basım Tarihi: 2019
  • Dergi Adı: Ege Tıp Dergisi
  • Derginin Tarandığı İndeksler: TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.149-153
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Aim: We aimed to investigate the alteration and distribution of seroprevalence of hepatitis B and hepatitis C withinthe years according to age groups in patients who applied to our hospital.Materials and Methods: The patients have been evaluated for six years retrospectively who were admitted to thirdstep hospital in Istanbul. The duplicate results of patients who submitted more than one application within the sameyear were excluded from this study. Male and female patients were divided into four age groups as 0-14, 14-25, 25-49 and over 49 years old. Electrochemiluminescence method (Roche Cobas 6000, Germany) was used for HBsAgand anti-HCV assays.Results: HBsAg positivity was 2.97% and anti-HCV positivity was 1.35%. HBsAg positivity was higher in males, andanti-HCV positivity was higher in females. No significant increase in seroprevalences of anti-HCV and HBsAg wasobserved during the six years observation period. HBsAg seroprevalences decreased in years especially in 0-14 and14-25 year-old male groups. HBsAg seroprevalence was not decreased in the other age groups over the years.There was no significant difference in anti-HCV seroprevalence over the years. HBsAg positivity was higher in malesand anti-HCV positivity was higher in females. Anti-HCV and HBsAg seroprevalence were not significantly differedover the years.Conclusion: It was remarkable that HBsAg positivity rate had decreased over the years especially in 0-14 and 14-25year-old males. Seroprevalence of HBsAg did not decrease in years in other age groups. There was no significantdifference in the seroprevalence of anti-HCV during the measurement period.